Free press releases distribution network?

Agency / Source: ZOLL Medical Corporation

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



ZOLL Announces Record Q4 and Annual Results - ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, announced that fiscal 2011 revenues were $523.7 million, compared to fiscal 2010 revenues of $444.0 million, an increase of 18%
ZOLL Announces Record Q4 and Annual Results

 

PRZOOM - /newswire/ - Chelmsford, MA, United States, 2011/11/16 - ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, announced that fiscal 2011 revenues were $523.7 million, compared to fiscal 2010 revenues of $444.0 million, an increase of 18%. NASDAQ: ZOLL

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

• Record Annual Revenues Exceeding $520M
• Record Annual EPS of $1.39 Grows 60%
• Record Q4 Revenue of $152M Grows 26%
• Record Q4 EPS of $0.52 Grows 58%

Revenue results reflected a positive foreign exchange impact of approximately $6 million. Net income for the year grew 65% to $31.3 million, compared to $18.9 million in the prior year. Gross margins improved to 57% on the year, compared to 54% in the prior year. Diluted earnings per share grew 60% to $1.39, compared to $0.87 in the prior year. Backlog at the end of the year was approximately $30 million, as compared to $14 million at the end of the prior fiscal year. The Company ended the year with approximately $75 million in cash and short-term investments and generated approximately $45 million in cash from operations during the year.

Annual sales to the North American market increased 6% to $273.3 million, compared to $258.5 million for the prior year. Sales to the North American hospital market increased 14% to $142.6 million, compared to $125.1 million last year. Excluding U.S. Military sales, North American hospital sales increased 8% to $110.7 million from $102.4 million. U.S. Military sales were $32.0 million, compared to $22.7 million in the prior year period. Sales to the North American pre-hospital market decreased 2% to $130.7 million, compared to $133.4 million in the prior year. International revenues increased 21% to $139.3 million, compared to $114.8 million last year. Total Temperature Management revenue grew 38% to $26.0 million, compared to $18.9 million in the prior year. Total LifeVest revenues (which are excluded from geographic sales figures) increased 57% to $111.0 million compared to $70.7 million last year. Total AutoPulse sales decreased 1% to $17.3 million for the year, compared to $17.5 million in the prior year.

Fourth quarter revenues increased 26% to $151.9 million, compared to revenues in the fourth quarter of last year of $120.4 million. Net income was $11.9 million for the quarter, an increase of 65% compared to $7.2 million in the prior year. Diluted earnings per share grew 58% to $0.52, compared to $0.33 in the prior year. Backlog at the end of the year was approximately $30 million, compared to $32 million at the end of Q3 2011.

Fourth quarter sales to the North American market were $83.5 million, an increase of 21% compared to $69.2 million for the prior-year period. Sales to the North American hospital market increased 31% to $46.2 million, compared to $35.2 million in the fourth quarter of last year. Excluding the U.S. Military, sales to the North American hospital market increased 28% to $33.5 million, compared to $26.3 million in the prior-year quarter. Sales to the U.S. Military were $12.7 million, an increase of $3.8 million, or 42% from the fourth quarter in the prior year. Sales to the North American pre-hospital market increased 10% to $37.3 million compared to $34.0 million in the same period last year. International sales increased 21% to $36.3 million, compared to $30.0 million in the fourth quarter last year. Total LifeVest revenues (which are excluded from geographic sales figures) increased 52% to $32.1 million. Total Temperature Management revenues grew 35% to $7.1 million, compared to $5.3 million in the fourth quarter last year. Total AutoPulse sales decreased 16% to $4.4 million, compared to $5.3 million in the same period of last year.

Gross margin for the fourth quarter was 58%, compared to 55% in the fourth quarter of fiscal 2010. The increase primarily reflected increased sales mix of higher margin LifeVest business and improved pricing in the North American core defibrillator business.

Commenting on the year, Richard A. Packer, Chief Executive Officer of ZOLL, stated, “2011 was a very strong year for ZOLL. Our annual revenues exceeded $520 million for the first time, making us the clear leader in the resuscitation market. We were particularly happy to outperform our bottom-line. The key revenue drivers included a strengthening of our core defibrillator business along with continued growth in both our LifeVest and Temperature Management businesses.”

With respect to Q4, Mr. Packer commented, “With another strong quarter, our core North America defibrillator business now appears to be gaining traction. We were very excited to see strong double-digit defibrillator growth in both our core Hospital and EMS businesses. In fact, order growth exceeded shipment growth in both of these businesses. Core International shipments continued to be strong as we relieved some of our pent up backlog. We believe we have momentum worldwide across our core defibrillator business.”

Mr. Packer observed, “The LifeVest experienced another very successful quarter. We eagerly await the results of the CMS reimbursement review. We remain very confident that the data and widespread cardiology support will validate the original DMAC decision to cover the LifeVest during critical ICD waiting periods. We saw very positive written support in favor of maintaining current reimbursement from all major medical associations including the Heart Rhythm Society (HRS), the American College of Cardiology (ACC), the American Heart Association (AHA), the American Stroke Association (ASA) and the American Association of Heart Failure Nurses (AAHFN). These institutions recognize the critical importance of maintaining access to the only available life-saving cardiac arrest treatment during the high risk ICD waiting periods for this country’s senior citizens. Both the clinical data and the clinical support for this product continue to grow. Additionally, we believe the overwhelming positive response from the clinical community during the public comment period bodes well for future adoption of this therapy.”

Mr. Packer further added, “We were pleased by the excitement generated at the AHA meeting in Orlando this past week. At the Resuscitation Science Symposium (ReSS) and subsequent meetings, 27 clinical presentations relating to ZOLL products were made. Highlights included the publication of CIRC trial results and presentations on the LifeVest. These presentations clearly reinforce the effectiveness of each product.”

Mr. Packer concluded, “Looking forward we anticipate 17-19% revenue growth in 2012 with acceleration in our core business. We expect the LifeVest and Temperature Management businesses to again achieve very high growth rates in 2012. We also expect our rate of profitability to improve as our core business continues to grow and our business mix continues to get more favorable. We expect to continue progress towards our goal of getting our long-term operating profitability into the mid-teens.”

ZOLL will host a conference call on Wednesday, November 16, 2011 at 5:00 p.m. EST to discuss its fourth quarter financial results. This conference call will be accessible on the Company’s home page. Recorded replays of this conference call will be available on the web page beginning later that day.

About ZOLL Medical Corporation
ZOLL Medical Corporation (zoll.com) develops and markets medical devices and related software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies which help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care.

A NASDAQ Global Select company and a Forbes 100 Most Trustworthy Company in 2007, 2008 and 2009, and a Forbes Top 100 Small Business Company in 2011, ZOLL develops and manufactures its products in the United States, in California, Colorado, Illinois, Massachusetts, Pennsylvania, and Rhode Island. More than 400 direct sales and service representatives, 1,100 business partners, and 200 independent representatives serve our customers in over 140 countries around the globe.

Certain statements contained in this press release, including statements regarding the anticipated development of the Company's business, the Company’s financial and operational guidance, the Company’s expectations regarding CMS reimbursement review of our LifeVest product, and other statements contained herein regarding matters that are not historical facts, are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, the risk of an unfavorable coverage determination with respect to our LifeVest product, and those other factors discussed in the section entitled “Risk Factors” in the Company's Annual Report on Form 10-K filed with the SEC on December 17, 2010 updated in the Company’s Quarterly Reports on Form 10-Q filed subsequently to the Form 10-K. You should not place undue reliance on the forward-looking statements in this press release, and the Company disavows any obligation to update or supplement those statements in the event of any changes in the facts, circumstances, or expectations that underlie those statements.

© 2011 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. AutoPulse, LifeVest, and ZOLL are registered trademarks of ZOLL Medical Corporation. All trademarks are property of their respective owners.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: ZOLL Medical Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


ZOLL Announces Record Q4 and Annual Results

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Diane Egan - Zoll.com 
978-421-9637 degan[.]zoll.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any ZOLL Medical Corporation securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From ZOLL Medical Corporation / Company Profile


Read Medical Services/Equipment Most Recent Related Press Releases:

Thales Launches the Pixium Portable 3543 DR Wifi Enabled Flat Panel Detector
GE Healthcare Showcases Industry-first Technologies and Digital Solutions, Focused on Improving Outcomes, At RSNA 2016
Agfa and LCsys Team Up to Launch ABSOLUT-ID, Their Turnkey Integrated Solution for the Production of High Security ID Cards
ZOLL Technology for Improving CPR Quality to be Showcased at American Heart Association Annual Conference
AccuVein to Exhibit Leading Vein Visualization Technology at American Society for Dermatologic Surgery Annual Meeting
US Biomedical Textiles Transform Implant Device Technology by Aligning to Changes in Patient Preference Finds Frost & Sullivan
Frost & Sullivan Commends Influence Health for Constantly Evolving its Patient Engagement Products to Accelerate Market Transformation
Frost & Sullivan Awards Carestream Top Honors for OnSight 3D Extremity System
Sparta Systems Launches the Next-Generation Cloud Solution Stratas QMS
Koning Wins Accolades from Frost & Sullivan for the Impressive Innovation Behind its Groundbreaking KBCT Breast Imaging Device

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  NAKIVO, Inc.

Visit  Triggr & Bloom







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today